High prevalence of exocrine pancreatic insufficiency in diabetes mellitus - A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients
High prevalence of exocrine pancreatic insufficiency in diabetes mellitus - A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients
复制标题
DOI:
10.1159/000073655
复制
发表时间:
2003-01-01
期刊:
影响因子:
3.6
通讯作者:
Kloer, HU
中科院分区:
文献类型:
--
作者:
Hardt, PD;Hauenschild, A;Kloer, HU
Background: There have been numerous reports on pancreatic exocrine dysfunction in diabetes mellitus using either direct or indirect function tests. The measurement of fecal elastase 1 concentrations (FEC) has been used as a screening tool for exocrine pancreatic disease in different patient groups indicating a high prevalence of exocrine dysfunction in diabetic populations. In this study we had the opportunity to study more than 1,000 diabetic patients to confirm recent observations in smaller populations. Methods: FEC were measured by ELISA in 323 patients with type 1 and 697 type 2 diabetes mellitus. Subjects with a history of alcohol abuse, gastrointestinal surgery, cancer or inflammatory diseases were not included. Diabetes history and clinical data were recorded using a standard case report form. Findings: 1,021 patients (334 female, 687 male; mean age 50 years; mean diabetes duration 11 years; mean age at onset of diabetes 39 years) were studied. FEC was normal (>200 mug/g) in 59.3% and severely reduced (